Results 91 to 100 of about 4,194 (200)

Single-Dose Pharmacokinetics of Famciclovir in Infants and Population Pharmacokinetic Analysis in Infants and Children

open access: yes, 2010
A multicenter, open-label study evaluated the single-dose pharmacokinetics and safety of a pediatric oral famciclovir (prodrug of penciclovir) formulation in infants aged 1 to 12 months with suspicion or evidence of herpes simplex virus infection ...
Kaiser, Guenther   +7 more
core   +1 more source

A rapidly-growing, heme-crusted lesion

open access: yesJAAD Case Reports, 2021
Adam Wynn, BS   +3 more
doaj   +1 more source

Antiviral Chemotherapy in Avian Medicine—A Review

open access: yesViruses
This review article describes the current knowledge about the use of antiviral chemotherapeutics in avian species, such as farm poultry and companion birds. Specific therapeutics are described in alphabetical order including classic antiviral drugs, such
Ines Szotowska, Aleksandra Ledwoń
doaj   +1 more source

Thymosin-α1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase

open access: yes, 2002
We examined whether combination therapy with thymosin-α1 and famciclovir would induce hepatitis B e antigen seroconversion in patients with chronic hepatitis B infection in the immune-tolerant phase without inducing significant hepatic necro-inflammation.
Nanji, A   +17 more
core   +1 more source

Comparison of Famciclovir, Valaciclovir, and Brivudine Treatments in Adult Immunocompetent Patients With Herpes Zoster

open access: yes, 2018
Herpes zoster (HZ) is a common disease characterized by the recurrence of varicella zoster, that stays dormant in sensory ganglia. The primary goal of this study was to compare efficiencies of famciclovir, valaciclovir, and brivudine in terms of pain ...
Erdem, Mustafa Teoman   +4 more
core   +1 more source

Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.

open access: yes, 2011
An open-label study evaluated the safety (n = 53) and pharmacokinetics (n = 8) of single-dose therapy with 1500 mg famciclovir (prodrug of penciclovir) for recurrent herpes labialis in adolescents.
Yogev, Ram   +7 more
core   +1 more source

Prevalence and clinical markers of herpes simplex virus infection in oral lesions of bullous pemphigoid

open access: yesFrontiers in Immunology
BackgroundThe manifestations of bullous pemphigoid (BP) and herpes simplex virus (HSV) infection are similar in oral mucosa, and the laboratory detection of HSV has some limitations, making it difficult to identify the HSV infection in oral lesions of BP.
Hanmei Zhang   +6 more
doaj   +1 more source

The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.

open access: yes, 2013
BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex. The present study was conducted using the zosteriform infection model in BALB/c mice.
Lyn Jennens (17260261)   +2 more
core   +1 more source

Formulation and In-vitro Evaluation of Famciclovir Floating Tablets by Melt Granulation Technique [PDF]

open access: yes, 2017
701-706Famciclovir is an antiviral drug agent which undergoes rapid biotransformation to the active antiviral compound penciclovir, which has inhibitory activity against herpes simplex virus.
Velivela, S   +3 more
core  

Novas perspectivas no Tratamento do Herpes Simples

open access: yesDST, 1995
As taxas crescentes de soroprevalência para o herpes simples vírus (HSV) são preocupantes nos países desenvolvidos. Uma grande parcela dos indivíduos portadores do vírus e assi ntornático. Os portadores sintomáticos da moléstia apresentam uma vasta gama
Omar Lupi da Rosa Santos   +2 more
doaj  

Home - About - Disclaimer - Privacy